Edition:
India

Gene Emery

Oral Novo Nordisk diabetes drug poses no more heart risk than placebo: study

12 Jun 2019

An experimental oral form of a Novo Nordisk drug for type 2 diabetes posed no greater risk of serious heart problems or death than a placebo in patients at high risk for such complications, according to data from a large study presented on Tuesday.

Experimental drug delays type 1 diabetes onset in mid-stage trial

09 Jun 2019

(Reuters Health) - In people at high risk for type 1 diabetes, 14 days of therapy with the experimental drug teplizumab delayed development of the disease by a year or more, according to results from a mid-stage study presented Sunday.

Vitamin D fails to prevent type 2 diabetes in large study

08 Jun 2019

(Reuters Health) - If you're talking vitamin D and expecting it to lower your risk of getting type 2 diabetes when you get older, it's time to lower your expectations.

Most face transplant patients continue to report better quality of life

30 May 2019

(Reuters Health) - Doctors at Brigham and Women's Hospital in Boston say most of the face transplant patients they have been following for about five years are continuing to show improvement in quality of life.

Progesterone only prevents miscarriage in women with history of pregnancy loss

09 May 2019

(Reuters Health) - Giving progesterone to women with bleeding early in pregnancy doesn't prevent pregnancy loss, except among women who have had a previous miscarriage, according to a study of 4,153 women treated at 48 hospitals in the UK.

St. Jude doctors claim cure for 'bubble boy' disease

18 Apr 2019

Relying on the trickery used by the AIDS virus to infect people, doctors at two medical centers say they have cured 10 infants of so-called bubble boy disease, a genetic defect that leaves children, typically boys, without an immune system.

More heart, lung transplants possible with therapy to clear Hep C from donor organs

04 Apr 2019

(Reuters Health) - The presence of hepatitis C in potential organ donors has long prevented hearts and lungs from going to patients who desperately need them, but that prohibition may soon disappear thanks to a technique that attacks the virus before it can gain a foothold in the recipient.

Doctors repeatedly accused of malpractice often quit or start practicing alone

28 Mar 2019

(Reuters Health) - The more malpractice claims a physician accrues, the greater the likelihood that doctor will switch to a smaller practice or stop practicing medicine altogether, a new study suggests.

With ADHD, amphetamine has double the psychosis risk of methylphenidate

21 Mar 2019

(Reuters Health) - Children and young adults with attention deficit-hyperactivity disorder (ADHD) who are treated with the stimulants amphetamine or methylphenidate face a small but significant risk of developing psychosis, with amphetamine products twice as likely to spark at problem, researchers say.

Cutbacks by some doctors halved new opioid prescriptions over 5 years

14 Mar 2019

(Reuters Health) - The rate of first-time opioid prescriptions declined 54 percent between 2012 and 2017 in the U.S., largely because many doctors stopped prescribing the painkillers, according to a study of more than 86 million people covered by private insurance.

World News